Outcomes Associated With Postoperative Dexamethasone Use After Adult Spinal Deformity Surgery
In brief
Postoperative dexamethasone was linked to more wound infections after spine surgery
In matched cohorts of 42,472 adults each, dexamethasone use within a week of spinal deformity surgery was associated with more wound infections at 30 days, 90 days, and 1 year, as well as other complications at later time points. Hospital-recorded mortality was lower in the dexamethasone group, but this observational study cannot establish cause and effect. Prospective studies are needed to define safe use.
- Journal
- Neurospine (Q1)
- Published
- 31 October 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Anthony M Price, Barbara Buccilli, Nathan Fredricks, Sean O'Leary, Soren Jonzzon, Christopher M Bonfield, et al.
- PMID
- 43000808
- DOI
- 10.14245/ns.2551772.886
Why clinicians should know about it
- Picked for Spine Surgery (top studies of the week, 15 November 2026): Large cohort examines complications after adult spinal deformity surgery
Abstract
OBJECTIVE: Dexamethasone is commonly prescribed following adult spinal deformity (ASD) surgery; however, dexamethasone's immunosuppressive effects on clinical outcomes in ASD surgery remain unclear. This study sought to: assess the effects of postoperative dexamethasone after ASD surgery, and evaluate the potential association between postoperative dexamethasone and complications. METHODS: This TriNetX study identified adults who underwent ASD surgery from 2009-2024. Outcomes were explored at 30-day, 90-day, and 1-year time points among patients with any systemic dexamethasone exposure within 7 days of surgery. Primary outcomes included wound infection, sepsis, and perioperative hematoma. Secondary outcomes included respiratory failure, delirium, new-onset diabetes, and in-hospital mortality. Propensity score matching (PSM) and logistic regression assessed associations. RESULTS: After PSM, 42,472 patients were included in both the dexamethasone and control cohorts. At 30 days, dexamethasone exposure was associated with higher odds of wound infection. At 90 days, these associations included elevated risks for wound infection, respiratory failure, delirium, and sepsis. By 1 year, dexamethasone use remained significantly associated with wound infection, delirium, and respiratory failure, however, hospital-recorded mortality was lower in the dexamethasone cohort. CONCLUSION: In this large cohort, postoperative dexamethasone exposure was associated with increased risks of infectious and hospital-based complications, including wound infection. These findings support the need for prospective studies to define safe perioperative protocols in complex spine surgery.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.